Navellier & Associates Inc Aurinia Pharmaceuticals Inc. Transaction History
Navellier & Associates Inc
- $915 Million
- Q3 2025
A detailed history of Navellier & Associates Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 83,780 shares of AUPH stock, worth $1.31 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
83,780Holding current value
$1.31 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
255Shares Held
61.2MCall Options Held
977KPut Options Held
616K-
Tang Capital Management LLC San Diego, CA10MShares$157 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$145 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$62.2 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$43.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$37.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.22B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...